Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsTranslating TrialsCase-Based Peer PerspectivesPodcastsVideosShorts
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Roger Lo, MD, PhD

Advertisement

Articles by Roger Lo, MD, PhD

Roger Lo on the Evolution of Melanoma During Therapy

ByRoger Lo, MD, PhD
December 9th 2015

Roger Lo, MD, PhD, UCLA Jonsson Comprehensive Cancer Center, discusses the evolution of metastatic melanoma during therapy.

Advertisement

Latest Updated Articles

  • Roger Lo on the Evolution of Melanoma During Therapy
    Roger Lo on the Evolution of Melanoma During Therapy

    December 9th 2015



Advertisement
Advertisement

Trending on Oncology Nursing News

1

NCCN Survey: US Cancer Centers Face Generic Oncology Drug Shortages

2

Solavia Decision Suite: Key Clinical Insights for APPs and PAs

3

FDA Grants Final Approval to Cabozantinib Capsules Across Multiple Solid Tumor Indications

4

FDA Approves Frontline Sevabertinib for HER2-Mutant Advanced NSCLC Patients

5

Frontline Sevabertinib Approved in HER2-Mutant NSCLC: Nursing Priorities

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us